Q3 2026 13F filing
Updated 6 days ago38 disclosed positions worth $753M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | E ENLIVEN THERAPEUTICS INC | $43.9M | 958.7K | 5.84% | — |
| 2 | G GUARDANT HEALTH INC | $39.1M | 219.3K | 5.19% | — |
| 3 | A ABIVAX SA | $38.1M | 384.6K | 5.06% | — |
| 4 | R ROIVANT SCIENCES LTD | $36M | 985.6K | 4.79% | — |
| 5 | U UNITED THERAPEUTICS CORP DEL | $32.5M | 60.1K | 4.32% | — |
| 6 | V VIRIDIAN THERAPEUTICS INC | $31.4M | 1.53M | 4.17% | — |
| 7 | A AXSOME THERAPEUTICS INC. | $29.9M | 162.4K | 3.98% | — |
| 8 | I INSMED INC | $28M | 245.7K | 3.72% | — |
| 9 | C CELCUITY INC | $26.2M | 329.1K | 3.48% | — |
| 10 | C CHARLES RIV LABS INTL INC | $25.6M | 86.8K | 3.40% | — |
| 11 | C CYTOKINETICS INC | $23.6M | 357.9K | 3.13% | — |
| 12 | B BRIDGEBIO PHARMA INC | $23.3M | 354.4K | 3.10% | — |
| 13 | P PRAXIS PRECISION MEDICINES I | $23M | 78.8K | 3.05% | — |
| 14 | O ORIC PHARMACEUTICALS INC | $21.2M | 1.57M | 2.82% | — |
| 15 | R REPLIGEN CORP | $20.8M | 108.4K | 2.77% | — |
| 16 | T TANGO THERAPEUTICS INC | $19.1M | 766.9K | 2.54% | — |
| 17 | R REVOLUTION MEDICINES INC | $18.9M | 92.3K | 2.52% | — |
| 18 | I INHIBRX BIOSCIENCES INC | $17.2M | 171.5K | 2.28% | — |
| 19 | N NEWAMSTERDAM PHARMA COMPANY | $17.1M | 702.4K | 2.27% | — |
| 20 | M VERADERMICS INC | $16.6M | 136.7K | 2.20% | — |
| 21 | C COGENT BIOSCIENCES INC | $16.5M | 515.0K | 2.19% | — |
| 22 | D DIANTHUS THERAPEUTICS INC | $15.7M | 178.6K | 2.09% | — |
| 23 | P PALVELLA THERAPEUTICS INC NE | $15.2M | 109.9K | 2.01% | — |
| 24 | R RHYTHM PHARMACEUTICALS INC | $15M | 157.6K | 1.99% | — |
| 25 | R ARCUS BIOSCIENCES INC | $14.9M | 577.7K | 1.98% | — |
| 26 | A ARROWHEAD PHARMACEUTICALS IN | $14.6M | 222.6K | 1.94% | — |
| 27 | I DISC MEDICINE INC | $14.4M | 220.7K | 1.92% | — |
| 28 | E ERASCA INC | $13.4M | 913.5K | 1.78% | — |
| 29 | G GRAIL INC | $13.1M | 93.7K | 1.74% | — |
| 30 | K KYMERA THERAPEUTICS INC | $12.7M | 113.3K | 1.68% | — |
| 31 | A ASCENDIS PHARMA A/S | $12.4M | 54.6K | 1.65% | — |
| 32 | Q UNIQURE NV | $11.2M | 465.5K | 1.49% | — |
| 33 | X XENON PHARMACEUTICALS INC | $11M | 297.1K | 1.47% | — |
| 34 | S SPYRE THERAPEUTICS INC | $9.1M | 102.5K | 1.21% | — |
| 35 | S SUMMIT THERAPEUTICS INC | $8.5M | 501.7K | 1.13% | — |
| 36 | D DEFINIUM THERAPEUTICS INC | $8.2M | 216.5K | 1.09% | — |
| 37 | P VAXCYTE INC | $7.8M | 137.5K | 1.04% | — |
| 38 | H HINGE HEALTH INC | $7.3M | 75.4K | 0.97% | — |